Neurophysiology Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (629)348-3199

Short Communication - Neurophysiology Research (2025) Volume 7, Issue 2

Brainstem Reflex Modulation and Its Association with Autonomic Dysfunction in Neurodegenerative Disorders

Michael Novak*

Department of Neurophysiology, Charles University, Czech Republic.

*Corresponding Author:
Michael Novak
Department of Neurophysiology
Charles University, Czech Republic.
E-mail: m.novak@charles.edu

Received: 03-Apr-2025, Manuscript No. AANR-25-169352; Editor assigned: 04-Apr-2025, PreQC No. AANR-25-1693525(PQ); Reviewed: 18-Apr-2025, QC No AANR-25-1693525; Revised: 21-Apr-2025, Manuscript No. AANR-25-1693525(R); Published: 28-Apr-2025, DOI:10.35841/aanr -7.2.195

Citation: Novak M. Brainstem reflex modulation and its association with autonomic dysfunction in neurodegenerative disorders. Neurophysiol Res. 2025;7(2):195.

Visit for more related articles at Neurophysiology Research

Introduction

Brainstem reflexes, such as the blink reflex, gag reflex, and baroreceptor-mediated cardiovascular responses, are critical indicators of the functional status of the central autonomic network. These reflexes are mediated through complex interactions within the brainstem, particularly in the medulla oblongata, pons, and midbrain, which coordinate both sensory input and motor output. In the context of neurodegenerative disorders, modulation of these reflexes becomes a focal point for understanding disease progression and symptomatology. Alterations in reflex responses often signal early involvement of autonomic circuits and reflect broader pathological processes affecting neuronal excitability and synaptic transmission. The evaluation of brainstem reflexes, particularly through electrophysiological techniques such as electromyography (EMG) and evoked potentials, offers a non-invasive window into the underlying neural dysfunctions and may aid in the early diagnosis and monitoring of disorders such as Parkinson’s disease, multiple system atrophy, and amyotrophic lateral sclerosis [1].

Autonomic dysfunction, a hallmark of many neurodegenerative diseases, often presents as orthostatic hypotension, gastrointestinal dysmotility, urinary incontinence, or cardiac irregularities. These clinical features stem from impaired autonomic reflex arcs, which are tightly regulated by the brainstem. In Parkinson’s disease, for example, degeneration of the dorsal motor nucleus of the vagus and other medullary centers disrupts parasympathetic tone, leading to reduced heart rate variability and abnormal blood pressure responses. The blink reflex, particularly its R2 component mediated by polysynaptic pathways in the brainstem, is frequently delayed or diminished in Parkinson’s and related disorders, correlating with the extent of autonomic failure. Similarly, in multiple system atrophy, which involves more diffuse degeneration of both sympathetic and parasympathetic centers, brainstem reflexes such as the Valsalva maneuver exhibit blunted responses, reinforcing the link between reflex modulation and systemic autonomic impairment [2].

Recent neurophysiological studies have highlighted the value of reflex testing in distinguishing between different neurodegenerative conditions based on their autonomic profiles. For instance, in amyotrophic lateral sclerosis (ALS), although the primary pathology affects motor neurons, studies show that autonomic dysfunction is not uncommon and may be detected through altered cardiovascular reflexes and abnormal sympathetic skin responses. These findings suggest that brainstem involvement is more widespread than traditionally thought. Moreover, brainstem auditory evoked potentials (BAEPs) and somatosensory evoked potentials (SSEPs) are increasingly used to assess central conduction times and to infer synaptic dysfunction in midbrain and pontine structures. The correlation between these evoked responses and clinical autonomic scores provides a quantitative measure of brainstem integrity. Furthermore, changes in reflex latencies and amplitudes can serve as biomarkers for disease staging, enabling clinicians to predict progression and customize management strategies based on autonomic burden [3].

The mechanisms underlying altered brainstem reflex modulation in neurodegenerative diseases are multifactorial. Neuronal loss, demyelination, neuroinflammation, and synaptic degeneration all contribute to disrupted neurotransmission within the autonomic nuclei. For example, α-synuclein aggregation in Parkinson’s disease and multiple system atrophy impairs normal function in the nucleus tractus solitarius and intermediolateral cell column, leading to reduced afferent and efferent autonomic signaling. These pathologies can be detected indirectly through attenuated reflex responses, such as diminished pupillary light reflex or delayed baroreflex sensitivity. In Alzheimer’s disease, while cognitive decline remains the primary feature, there is growing evidence of concurrent autonomic disturbances, possibly linked to tau pathology affecting brainstem structures. EEG and EMG-based studies of startle and blink reflexes in Alzheimer’s patients reveal prolonged latencies and decreased habituation, consistent with altered brainstem excitability. These electrophysiological signatures are instrumental in differentiating Alzheimer’s from other dementias that show more pronounced autonomic features, such as Lewy body dementia [4].

Therapeutic interventions targeting autonomic dysfunction have shown varying degrees of success, often dependent on the extent of brainstem involvement. Pharmacological treatments aimed at modulating sympathetic or parasympathetic output, such as midodrine for orthostatic hypotension or anticholinergics for bladder dysfunction, provide symptomatic relief but do not address the underlying reflex abnormalities. Non-pharmacological approaches, including biofeedback and vagus nerve stimulation, are being explored to enhance autonomic tone and potentially modulate reflex responsiveness. Neurophysiological monitoring of brainstem reflexes can help guide these interventions, offering real-time feedback on treatment efficacy. Additionally, longitudinal studies suggest that regular assessment of reflex modulation may serve as a sensitive tool for tracking disease progression and evaluating the impact of emerging disease-modifying therapies. As our understanding of the neurophysiological basis of autonomic dysfunction expands, integrating reflex testing into routine clinical evaluations may improve diagnostic precision and patient outcomes across a range of neurodegenerative disorders [5].

Conclusion

The modulation of brainstem reflexes offers a vital lens through which autonomic dysfunction in neurodegenerative disorders can be understood and assessed. These reflexes, intricately governed by central autonomic pathways, exhibit measurable alterations in diseases such as Parkinson’s, multiple system atrophy, ALS, and even Alzheimer’s. Neurophysiological tools that capture these changes—through EMG, EEG, and evoked potentials—provide valuable, non-invasive means of evaluating disease severity, monitoring progression, and tailoring therapeutic strategies. Importantly, the differential patterns of reflex impairment help distinguish between disorders with overlapping clinical features but distinct underlying pathologies. As research continues to unravel the complexities of brainstem-autonomic interactions, reflex testing is poised to become an integral part of clinical practice, offering both diagnostic clarity and deeper insights into disease mechanisms.

References

  1. D’Ostilio K, Magis D. Invasive and non-invasive electrical pericranial nerve stimulation for the treatment of chronic primary headaches. Curr Pain Headache Rep. 2016;20:1-9.
  2. Indexed at, Google Scholar, Crossref

  3. Deer T, Masone RJ. Selection of spinal cord stimulation candidates for the treatment of chronic pain. Pain Med. 2008;9:82-92.
  4. Indexed at, Google Scholar, Crossref

  5. Nizard J, Lefaucheur JP, Helbert M, et al. Non-invasive stimulation therapies for the treatment of refractory pain. Discov Med. 2012;14(74):21-31.
  6. Indexed at, Google Scholar

  7. O'Halloran KD. A shock to the system: neurostimulation therapy for opioid-induced respiratory depression. J Physiol. 2022;600(12):2833.
  8. Indexed at, Google Scholar, Crossref

  9. Walter M, Sammer U, Kessler TM. Chronic pelvic pain syndrome: neurostimulation, neuromodulation and acupuncture. Der Urologe. 2012;51:1683-91.
  10. Indexed at, Google Scholar, Crossref

Get the App